Related references
Note: Only part of the references are listed.ApoE (Apolipoprotein E) in Brain Pericytes Regulates Endothelial Function in an Isoform-Dependent Manner by Modulating Basement Membrane Components
Yu Yamazaki et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease
Yingyue Zhou et al.
NATURE MEDICINE (2020)
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Eric M. Reiman et al.
NATURE COMMUNICATIONS (2020)
ApoE mimetic improves pathology and memory in a model of Alzheimer's disease
Kamesh Krishnamurthy et al.
BRAIN RESEARCH (2020)
Association of Apolipoprotein E epsilon 4 With Medial Temporal Tau Independent of Amyloid-beta
Joseph Therriault et al.
JAMA NEUROLOGY (2020)
Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4
Michael E. Belloy et al.
JAMA NEUROLOGY (2020)
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Axel Montagne et al.
NATURE (2020)
LRP1 is a master regulator of tau uptake and spread
Jennifer N. Rauch et al.
NATURE (2020)
Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
Na Zhao et al.
NEURON (2020)
Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes
Joel W. Blanchard et al.
NATURE MEDICINE (2020)
Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans
Aziz M. Mezlini et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Single-cell transcriptomic analysis of Alzheimer's disease
Hansruedi Mathys et al.
NATURE (2019)
Assessment of APOE in atypical parkinsonism syndromes
Marya S. Sabir et al.
NEUROBIOLOGY OF DISEASE (2019)
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Ross Nortley et al.
SCIENCE (2019)
Non-coding variability at the APOE locus contributes to the Alzheimer's risk
Xiaopu Zhou et al.
NATURE COMMUNICATIONS (2019)
Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype
Yiyi Ma et al.
JAMA NEUROLOGY (2019)
Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review
Aamira J. Huq et al.
ALZHEIMERS & DEMENTIA (2019)
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
Yang Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model
Tien-Phat V. Huynh et al.
MOLECULAR NEURODEGENERATION (2019)
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report
Joseph F. Arboleda-Velasquez et al.
NATURE MEDICINE (2019)
A single-cell atlas of entorhinal cortex from individuals with Alzheimer's disease reveals cell-type-specific gene expression regulation
Alexandra Grubman et al.
NATURE NEUROSCIENCE (2019)
Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer's disease
Jonathan Mauricio Munoz-Cabrera et al.
PLOS ONE (2019)
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Samira Parhizkar et al.
NATURE NEUROSCIENCE (2019)
Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics
Elizabeth E. Blue et al.
ALZHEIMERS & DEMENTIA (2019)
Association of Apolipoprotein E ε4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
Vijay K. Ramanan et al.
JAMA NETWORK OPEN (2019)
ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology
Carolin Koriath et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)
Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-epsilon 4/TOMM40 long poly-T repeat allele variants
Inga Prokopenko et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Haplotype analysis of APOE intragenic SNPs
Vladimir N. Babenko et al.
BMC NEUROSCIENCE (2018)
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
John L. Robinson et al.
BRAIN (2018)
A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type
Eleanna Kara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
Fan Liao et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
ApoE facilitates the microglial response to amyloid plaque pathology
Jason D. Ulrich et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types
Yuan-Ta Lin et al.
NEURON (2018)
Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study
Hyun-Sik Yang et al.
LANCET NEUROLOGY (2018)
APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology
Dennis W. Dickson et al.
NEUROLOGY (2018)
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism
Qingyi Ma et al.
MOLECULAR NEURODEGENERATION (2018)
APOE ε2 is associated with increased tau pathology in primary tauopathy
Na Zhao et al.
NATURE COMMUNICATIONS (2018)
Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations
Farid Rajabli et al.
PLOS GENETICS (2018)
Reversal of ApoE4-induced recycling block as a novel prevention a proach for Alzheimer's disease
Xunde Xian et al.
ELIFE (2018)
Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43
Alexandra M. Wennberg et al.
JAMA NEUROLOGY (2018)
APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes
Jing Zhao et al.
HUMAN MOLECULAR GENETICS (2017)
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Susanne Krasemann et al.
IMMUNITY (2017)
Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay
Eleanna Kara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition
Chia-Chen Liu et al.
JOURNAL OF NEUROSCIENCE (2017)
APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice
Joanna E. Pankiewicz et al.
MOLECULAR NEURODEGENERATION (2017)
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Yang Shi et al.
NATURE (2017)
Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis
Tien-Phat V. Huynh et al.
NEURON (2017)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Chia-Chen Liu et al.
NEURON (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease
Alberto Serrano-Pozo et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies
Anat Boehm-Cagan et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes
Won-Suk Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
APOEε2 is associated with milder clinical and pathological Alzheimer disease
Alberto Serrano-Pozo et al.
ANNALS OF NEUROLOGY (2015)
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Yuka Atagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Role of Apolipoprotein E in β-Amyloidogenesis ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF Aβ IN VITRO AND BRAIN Aβ DEPOSITION IN VIVO
Yukiko Hori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
Jin Hu et al.
MOLECULAR NEURODEGENERATION (2015)
Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy
Kenji Sakai et al.
ACTA NEUROPATHOLOGICA (2014)
Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo
Leon M. Tai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Anti-ApoE Antibody Given after Plaque Onset Decreases Aβ Accumulation and Improves Brain Function in a Mouse Model of Aβ Amyloidosis
Fan Liao et al.
JOURNAL OF NEUROSCIENCE (2014)
Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease
Judes Poirier et al.
NEUROBIOLOGY OF AGING (2014)
Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function
Angel C. Y. Mak et al.
JAMA NEUROLOGY (2014)
Neuronal Clearance of Amyloid-β by Endocytic Receptor LRP1
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2013)
The Apolipoprotein-E-Mimetic COG112 Protects Amyloid Precursor Protein Intracellular Domain-Overexpressing Animals from Alzheimer's Disease-Like Pathological Features
Kaushik Ghosal et al.
NEURODEGENERATIVE DISEASES (2013)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Nicholas F. Fitz et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Ina Tesseur et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Karthikeyan Veeraraghavalu et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Ashleigh R. Price et al.
SCIENCE (2013)
Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain
Eloise Hudry et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Pericyte loss influences Alzheimer-like neurodegeneration in mice
Abhay P. Sagare et al.
NATURE COMMUNICATIONS (2013)
APOE ε4 Increases Risk for Dementia in Pure Synucleinopathies
Debby Tsuang et al.
JAMA NEUROLOGY (2013)
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β
Robert M. Koffie et al.
BRAIN (2012)
Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice
Danubia B. Santos et al.
EXPERIMENTAL NEUROLOGY (2012)
APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
Katherine L. Youmans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
Jungsu Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2012)
Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide
Tadafumi Hashimoto et al.
JOURNAL OF NEUROSCIENCE (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
APOE-Mimetic Peptides Reduce Behavioral Deficits, Plaques and Tangles in Alzheimer's Disease Transgenics
M. P. Vitek et al.
NEURODEGENERATIVE DISEASES (2012)
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis
Joseph M. Castellano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
Jungsu Kim et al.
NEURON (2009)
Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Incidence of Alzheimer disease in a biracial urban community - Relation to apolipoprotein E allele status
DA Evans et al.
ARCHIVES OF NEUROLOGY (2003)
The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: Implications for Alzheimer's disease
D Champagne et al.
NEUROSCIENCE (2003)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
DM Holtzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
